📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia. (2018)

First Author: Peng F

Attributed to: Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2017.368

PubMed Identifier: 29106390

Publication URI: http://europepmc.org/abstract/MED/29106390

Type: Journal Article/Review

Volume: 37

Parent Publication: Oncogene

Issue: 8

ISSN: 0950-9232